Vimarsana
Biggest News Aggregation in the World

Page 3 - Greg Reybold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Reybold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Reybold Today - Breaking & Trending Today

Pharmacy groups laud FTC probe into pharmacy benefit managers' practices - Vimarsana News

Pharmacy groups laud FTC probe into pharmacy benefit managers' practices

A number of pharmaceutical groups have come out in favor of the Federal Trade Commission's decision to launch an inquiry into the business practices of the nation's six largest pharmacy benefit managers, in order to scrutinize their impact on the access and affordability of prescription drugs. The FTC announced this week that it's sending compulsory orders to CVS Caremark,

PBM Practices Under FTC Scrutiny; APCI Applauds Decision - Vimarsana News

PBM Practices Under FTC Scrutiny; APCI Applauds Decision

BESSEMER, Ala., June 7, 2022 /PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) applauds the decision by the U.S. Federal Trade Commission...

PBM Practices Under FTC Scrutiny; APCI Applauds Decision - Vimarsana News

PBM Practices Under FTC Scrutiny; APCI Applauds Decision

/PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) applauds the decision by the U.S. Federal Trade Commission (FTC) to launch a study into the...

PBM Practices Under FTC Scrutiny; APCI Applauds Decision - Vimarsana News

PBM Practices Under FTC Scrutiny; APCI Applauds Decision

/PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) applauds the decision by the U.S. Federal Trade Commission (FTC) to launch a study into the...

Anti-competitive Drug Middlemen Practices Harming Patients, Payers, and Pharmacies, APCI Tells FTC - Vimarsana News

Anti-competitive Drug Middlemen Practices Harming Patients, Payers, and Pharmacies, APCI Tells FTC

/PRNewswire/ -- The federal government must use its authority to scrutinize and police anti-competitive practices used by middlemen in the prescription drug...